Our Leadership
Medlink Inc. Board of Directors & Executive Leadership
Medlink Inc. is led by a distinguished group of physicians, scientists, pharmaceutical executives, and global logistics experts whose combined experience spans clinical medicine, pharmaceutical research, biotechnology, regulatory affairs, manufacturing, and international supply chain operations.
Our leadership team is uniquely positioned at the intersection of science, medicine, and global trade, ensuring that every decision made within Medlink aligns with the highest standards of clinical integrity, regulatory compliance, operational excellence, and patient safety.
Each member of our leadership team brings a proven record of achievement across leading institutions, global pharmaceutical organizations, and advanced research environments.
More About Us
Michael Moharan, MD
Chief Executive Officer
Dr. Michael Moharan serves as Chief Executive Officer of Medlink Inc. and leads the organization with a strong foundation in both clinical medicine and pharmaceutical science. His background uniquely combines medical practice, pharmacy education, and pharmaceutical research, allowing him to bridge clinical understanding with global pharmaceutical operations.
Education
- MD: Columbia University College of Physicians and Surgeons (2010)
- PharmD: St. John’s University, New York (2006)
- Advanced training in Orthopedic Foot & Ankle Surgery
- Affiliated with Hospital for Special Surgery (HSS), New York
Key Highlights
- Research Investigator at Novartis Pharmaceuticals (2005–2007)
- Worked on reducing cardiotoxicity of Doxorubicin chemotherapy
- Early experience in pharmacy operations at Duane Reade Pharmacy
- Clinical background in orthopedic surgical practice
Combines expertise in medicine, pharmacy, and pharmaceutical research with healthcare operations leadership.
Asmahan Talaat, MD
Chief Financial Officer
Dr. Asmahan Talaat is a medical executive with strong expertise in global pharmaceutical strategy, financial oversight, and cross-border healthcare systems. She plays a key role in aligning U.S. pharmaceutical standards with international regulatory environments, particularly across the MENA region.
Education:
- MD: Ain Shams University, Cairo, Egypt
Key Highlights:
- Expertise in U.S. and MENA healthcare system integration
- Experience in pharmaceutical research and distribution strategy
- Specializes in FDA and MENA regulatory alignment
- Supports international pharmaceutical expansion frameworks
Specialist in bridging financial, regulatory, and operational systems between U.S. and MENA healthcare markets.
Dr. Aliza Apple, Ph.D
Senior Board Member
Dr. Aliza Apple is a biotechnology and pharmaceutical innovation expert with extensive experience in bioengineering, artificial intelligence systems, and global pharmaceutical strategy. Her work focuses on advancing collaborative pharmaceutical technologies and biotech ecosystems.
Education:
- Ph.D. Bioengineering: UC Berkeley & UCSF
- Postdoctoral Fellowship: Cornell Medical College (NIH-supported)
- B.Sc. Physics: Georgetown University
Key Highlights:
- Developed Lilly TuneLab AI pharmaceutical collaboration platform
- Former Partner at McKinsey & Company (9 years)
- Co-founder of Santa Ana Bio (precision biologics company)
- COO of Lilly Gateway Labs West Coast
- Board Member, Biocom California
Leader in biotech innovation, AI integration in pharma, and strategic pharmaceutical advisory.
Dr. Anwesha Dey, Ph.D
Executive Director & Senior Advisor
Dr. Anwesha Dey is a structural biology and oncology research expert specializing in drug discovery and AI-driven biomedical innovation. She contributes to advancing cancer therapies and translational medicine research globally.
Education:
- Ph.D. Structural Biology: UMBC
- Postdoctoral Research: Genentech
- Biotechnology Studies: National University of Singapore (ASTAR Scholar)
Key Highlights:
- Contributed to FDA-approved cancer therapy (Itovebi)
- Leads AI-integrated oncology research at Genentech
- Named 2024 Emerging Leader in Health & Medicine (NAM)
- Recipient of Genentech Changemaker Award
- Recognized global speaker in oncology research
Expert in oncology drug development, AI-based research systems, and advanced biological sciences.
Josh Medow
Senior Advisor – Logistics & Supply Chain
Josh Medow is a global logistics and supply chain specialist with deep expertise in pharmaceutical cold-chain distribution and international transport systems. He ensures sensitive medical products are delivered safely and efficiently across global markets.
Key Highlights:
- Specialist in pharmaceutical cold-chain logistics
- Experience in vaccine and clinical trial sample transport
- Scaled Mercury Inc by 120% in biotech logistics sector
- Named 2026 Rising Star (Supply & Demand Chain Executive)
- Senior Advisor to MedLink Board
Expert in global pharmaceutical logistics, cold-chain systems, and supply chain optimization.
Dr. Rao Mantri, Ph.D
Senior Business Executive & Board Advisor
Dr. Rao Mantri is a pharmaceutical manufacturing and operations strategist focused on transforming global supply chains through AI-driven forecasting and advanced production systems. His work supports scalable, resilient pharmaceutical manufacturing networks.
Key Highlights:
- Ph.D. Pharmaceutical Sciences
- Expert in pharmaceutical manufacturing systems
- Focus on AI-driven supply chain optimization
- Specializes in cell and gene therapy manufacturing systems
- Speaker at American Biomanufacturing Summit
Leader in pharmaceutical manufacturing strategy, AI integration, and global production system design.
Start a Fully Compliant Pharmaceutical Partnership
Work with a U.S.-registered pharmaceutical exporter operating under FDA, DEA, and international regulatory frameworks. Built for institutions that require reliability, documentation, and full compliance at every step of the global supply chain.
Get in Touch With Medlink